Osborne Clarke
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Osborne Clarke is described as ‘highly specialised'’ in the healthcare and life sciences market. Maria Grazia Medici heads the team, advising on the sale of pharma business units, litigation before the Administrative Court of Lazio and product defect disputes. The team also advises on payback obligations, marketing, and the advertising of pharma products on app-based platforms. Federico M Ferrara focuses on acquisitions and post-acquisition regulatory and contractual matters, including over-the-counter businesses, while Giulia Verusio advises on the sale of medicinal products and broader regulatory compliance issues.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Support the activities by making non-experts understand the core consequences and implications in the business.’
- ‘Their competence and availability to solve issues in a short time.’
Key clients
- Dentsply Sirona Italia S.r.l.
- DSM Venturing BV
Work highlights
Advised Grifols Italia S.p.A. on legal and regulatory matters, including the challenge of a €122 million plasma fractioning tender and the annulment of a €14 million haemoderivatives tender.